Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: An in vitro study

Carcinogenesis

Volumn 22, Issue 8, 2001, Pages 1139-1148

  Denoyelle, Christophe ^a   Vasse, Marc ^a   Körner, Marie ^b   Mishal, Zohair ^c   Ganné, Florence ^a   Vannier, Jean Pierre ^a   Soria, Jeannette ^d   Soria, Claudine ^a,e  

^a UNIVERSITÉ DE ROUEN   (France)

^b CNRS UPR 9079 Oncogenese Differenciation et Transduction du Signal   (France)

^c CNRS   (France)

^d HÔTEL DIEU   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CERIVASTATIN; CHOLESTEROL; FARNESYL DIPHOSPHATE; FARNESYL TRANS TRANSFERASE; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MATRIGEL; PROTEIN P21; RAS PROTEIN; RHO FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UROKINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; INHIBITION KINETICS; METASTASIS; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 0034908034     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.8.1139     Document Type: Article

References (45)

1. Non-lipid-related effects of statins
2. Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma
3. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering
4. Increasing complexity of Ras signaling
5. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells
6. The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB-231
7. Rho GTPases are over-expressed in human tumors
8. RhoA prenylation is required for promotion of cell growth and transformation, cytoskeleton organization, but not for induction of SRE transcription
9. Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho-GDI) in cell motility
10. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells
11. Signal transduction through MAP kinase cascades
12. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins
13. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1
14. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth
15. A novel complex between the p65 subunit of NF-κB and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene
16. Regulation of the tissue factor gene
17. Synergistic up-regulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-Kappa B
18. Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer
19. Clinical impact of the plasminogen activation system in tumour invasion and metastasis: Prognostic relevance and target for therapy
20. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system
21. Tissue factor in cancer angiogenesis and metastasis
22. Suppression of TNF-α induced apoptosis by NF-κB
23. An essential role for NF-κB in preventing TNF-α induced cell death
24. TNF-α and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
25. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis
26. 2+-regulated kinases
27. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding
28. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus
29. Characterization of the human immunodeficiency virus type 1 enhancer-binding proteins from the human T-cell line Jurkat
30. Domain organization of IκB and sites of interaction with NF-κB p65
31. Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains
32. Breast cancer (1)
33. Microinjection of recombinant p21rho induces rapid changes in cell morphology
34. 1
35. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1
36. Tumorigenic activity of rho genes from Aplysia california
37. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
38. Critical role of Rho in cell transformation by oncogenic Ras
39. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion
40. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-Kappa B
41. LDL receptor related protein internalizes and degrades u-PA-PAI-1 complexes is essential for embryo implantation
42. Activation of tissue-factor gene expression in breast carcinoma by stimulation of the RAF-ERK signaling pathway
43. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells
44. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells
45. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells